It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2017.
2017 | Chennai, Tamil Nadu, India | ActiveTricept Pharmaceuticals Private Limited, a active private limited company, was established on 13 September 2017 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TN2017PTC118587. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Uday Medisales Private Limited. It upholds a compliant status. Its leadership includes Ganesan Magesh (Director), Kamal Chand (Director). Past directors included Babithajain, Kamal Chand, Saurab Jain. It holds ₹1.54 Cr open charges and ₹8.90 M settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Kuppa Swamy Complex 34/6, Raja Bather Street, T.Nagar, Chennai, Tamil Nadu, 600017.
U51909TN2017PTC118587
118587
13 September 2017
₹1.00 M
₹1.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Tricept Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesan Magesh | Director | 15 Mar 2019 | Current |
| Kamal Chand | Director | 14 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Mar 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tricept Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 97.18% decrease. The company also saw a substantial improvement in profitability, with a 100.97% increase in profit. The company's net worth moved up by a moderate rise of 1.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Tricept Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,400,000.00
₹8,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2020 | Others | ₹1.54 Cr | Open |
| 04 Jun 2020 | Indian Bank | ₹1.20 M | Satisfied |
| 09 Apr 2020 | Indian Bank | ₹0.70 M | Satisfied |
| 05 Aug 2019 | Indian Bank | ₹7.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Tricept Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tricept Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tricept Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Tricept Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Tricept Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chennai. was recorded as a recent event.
Progress on Kamal Chand was appointed as a Director was appointed as a Director on 14 Mar 2022 & has been associated with this company since 3 years 9 months . was documented.
Progress on A charge registered on 04 Jun 2020 via Charge ID 100345853 with Indian Bank was fully satisfied on 20 Jan 2021. was documented.
Progress on A charge registered on 09 Apr 2020 via Charge ID 100345855 with Indian Bank was fully satisfied on 20 Jan 2021. was documented.
A charge registered on 05 Aug 2019 via Charge ID 100291506 with Indian Bank was fully satisfied on 20 Jan 2021. was recorded as a recent event.
The CIN of Tricept Pharmaceuticals Private Limited is U51909TN2017PTC118587.
Tricept Pharmaceuticals Private Limited is headquartered at Kuppa Swamy Complex 34/6, Raja Bather Street, T.Nagar, Chennai, Tamil Nadu, 600017.
Tricept Pharmaceuticals Private Limited was incorporated on 13 September 2017.
The current directors of Tricept Pharmaceuticals Private Limited are
The primary industry of Tricept Pharmaceuticals Private Limited is Trade.
Tricept Pharmaceuticals Private Limited is unlisted.
The authorized capital of Tricept Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Tricept Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX